Epidemiological and etiological characteristics of hand, foot and mouth disease among children aged 5 years and younger in Ningbo (2016 to 2019)

  • Li-li LIU ,
  • Zhi-ke LIU ,
  • Liang ZHANG ,
  • Ning LI ,
  • Ting FANG ,
  • Dong-liang ZHANG ,
  • Guo-zhang XU ,
  • Si-yan ZHAN
Expand
  • 1. Department of Epidemiology and Biostatistics, Peking University School of Public Health, Beijing 100191, China
    2. Ningbo Municipal Center for Disease Control and Prevention, Ningbo 315010, Zhejiang, China

Received date: 2021-02-08

  Online published: 2021-06-16

Supported by

National Natural Science Foundation of China(81973146);National Key Research and Development Program of China(2018ZX10201002-3-8)

Abstract

Objective: To describe the epidemiological and etiological characteristics of hand, foot and mouth disease (HFMD) among children aged 5 years and younger in Ningbo after the access of entero-virus-A71 vaccine (2016 to 2019). Methods: A retrospective cohort study were performed in children aged 5 years and younger in Ningbo from 2016 to 2019. Data for incidence of HFMD was collected from the National Notifiable Disease Surveillance Reporting System and the Electronic Medical Records (EMRs) System, while the demographic information was derived from the Immunization Information System. Speci-mens were detected by real-time fluorescence quantitative PCR and the Wilson method was used to estimate the incidence rate and 95% confidence interval. Results: From 2016 to 2019, a total of 1 044 800 residential children were observed in this population-based cohort. In the study, 102 471 cases of HFMD were diagnosed in 2 651 081 person-years, revealing an overall incidence density of 3 865.25/100 000 person-years. There was no significant decline in the number of the cases after the vaccine was available. The number of the patients of hand foot mouth disease during the four years was 93 421, of whom 84 875 (90.85%) had only one incident record, while 8 946 (9.15%) had 2 or more cases in this period; there were 69 771 (66.06%) patients who only needed to see a doctor once for each disease, 19.92% of the patients needed to be treated twice, and 14 801 (14.02%) patients needed to go to the hospital or clinic three times or more. The incidence of HFMD showed obvious seasonality and periodicity, which mainly concentrated in April to July each year, and the epidemic cycle was 2 years; most of the cases were 1 to 3-year old children, with more cases in male. The incidence density varied across the region, with the highest density observed in Ninghai (4 524.76/100 000 person-years), followed by Xiangshan (3 984.22/100 000 person-years). In 3 748 library-conformed cases, 2 834(75.61%) were detected positive, among which enterovirus-A71, Cox-A16 and other enteroviruses accounted for 9.03%, 31.55% and 59.42%, respectively. During the study period, the cumulative coverage of enterovirus-A71 vaccine increased year by year, with the proportion of enterovirus-A71 and severe cases both gradually decreasing. Conclusion: The current status of hand, foot and mouth disease in Ningbo is still serious. Children under 3-year old (especially male children aged 1 year) were the key population for prevention and control. Vaccination might lead to changes in major pathogenic virus type, of which more attention should be paid to the potential impact on disease surveillance, prevention and control.

Cite this article

Li-li LIU , Zhi-ke LIU , Liang ZHANG , Ning LI , Ting FANG , Dong-liang ZHANG , Guo-zhang XU , Si-yan ZHAN . Epidemiological and etiological characteristics of hand, foot and mouth disease among children aged 5 years and younger in Ningbo (2016 to 2019)[J]. Journal of Peking University(Health Sciences), 2021 , 53(3) : 491 -497 . DOI: 10.19723/j.issn.1671-167X.2021.03.009

References

[1] Xie C, Wen H, Yang W, et al. Trend analysis and forecast of daily reported incidence of hand, foot and mouth disease in Hubei, China by prophet model[J]. Sci Rep, 2021,11(1):1445.
[2] Tyring S. Hand foot and mouth disease: enteroviral load and disease severity[J]. EBioMedicine, 2020,62(12):103115.
[3] Schmidt C. More cases of hand, foot, and mouth disease in China: a consequence of climate change[J]. Environ Health Perspect, 2018,126(9):94002.
[4] Li Y, Zhou Y, Cheng Y, et al. Effectiveness of EV-A71 vaccination in prevention of paediatric hand, foot, and mouth disease associated with EV-A71 virus infection requiring hospitalisation in Henan, China, 2017-18: a test-negative case-control study[J]. Lancet Child Adolesc Health, 2019,3(10):697-704.
[5] Li Y, Chang Z, Wu P, et al. Emerging enteroviruses causing hand, foot and mouth disease, China, 2010—2016[J]. Emerg Infect Dis, 2018,24(10):1902-1906.
[6] 许国章, 倪红霞, 易波, 等. 浙江省宁波市2008—2011年手足口病流行病学及病原学特征分析[J]. 中华流行病学杂志, 2013,34(4):361-365.
[7] 丁克琴, 陈奕, 谢蕾, 等. 2011—2015年宁波市手足口病流行病学与病原学特征分析[J]. 现代预防医学, 2016,43(23):4251-4254, 4263.
[8] Zhu F, Xu W, Xia J, et al. Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China[J]. N Engl J Med, 2014,370(9):818-828.
[9] Liu Z, Zhang L, Yang Y, et al. Active surveillance of adverse events following human papillomavirus vaccination: feasibility pilot study based on the regional health care information platform in the city of Ningbo, China[J]. J Med Internet Res, 2020,22(6):e17446.
[10] Huang J, Liao Q, Ooi M, et al. Epidemiology of recurrent hand, foot and mouth disease, China, 2008—2015[J]. Emerg Infect Dis, 2018,24(3):432-442.
[11] 国家统计局. 人口和就业[EB/OL]. (2020-06-19)[2021-01-20]. http://www.stats.gov.cn/tjzs/cjwtjd/201308/t20130829_74322.html.
[12] 叶科军. 丙种球蛋白治疗小儿重症手足口病疗效观察[J]. 吉林医学, 2013,34(32):6733-6734.
[13] 张静, 靳妍, 孙军玲, 等手足口病重症病例临床分期与结局分析[J]. 中华流行病学杂志, 2017,38(5):651-655.
[14] 任敏睿, 崔金朝, 聂陶然, 等. 2008—2018年中国手足口病重症病例流行病学特征分析[J]. 中华流行病学杂志, 2020,41(11):1802-1807.
[15] 王笑笑, 蔡剑, 韩桃利, 等. 2009—2017年浙江省手足口病流行病学特征及病原学监测分析[J]. 中华实验和临床病毒学杂志, 2019,33(1):1-5.
[16] 陈琦, 邢学森, 吴杨, 等. 湖北省2009—2015年手足口病流行病学和病原学分析[J]. 中华流行病学杂志, 2017,38(4):441-445.
[17] 金丽珠, 葛辉, 杜雪杰, 等. 2015年全国医疗机构法定传染病报告质量调查分析[J]. 疾病监测, 2016,31(10):883-886.
[18] 陈飒, 赵斌, 刘艳, 等. 陕西省2009—2018年手足口病流行特征及动态变化分析[J]. 中华流行病学杂志, 2019,40(9):1120-1124.
[19] Guan X, Che Y, Wei S, et al. Effectiveness and safety of an inactivated enterovirus 71 vaccine in children aged 6-71 months in a phase Ⅳ study[J]. Clin Infect Dis, 2020,71(9):2421-2427.
[20] Jiang L, Wang J, Zhang C, et al. Effectiveness of enterovirus A71 vaccine in severe hand, foot, and mouth disease cases in Guangxi, China[J]. Vaccine, 2020,38(7):1804-1809.
[21] 黄威, 陈雨, 罗恺炜 等. 湖南省2008—2017年手足口病病原学与流行特征分析[J]. 中华实验和临床病毒学杂志, 2019,33(1):16-20.
[22] Fan S, Liao Y, Jiang G, et al. Efficacy of an inactivated bivalent vaccine for enterovirus 71 and coxsackievirus A16 in mice immunized intradermally[J]. Vaccine, 2021,39(3):596-604.
[23] Liu D, Leung K, Jit M, et al. Cost-effectiveness of bivalent versus monovalent vaccines against hand, foot and mouth disease[J]. Clin Microbiol Infect, 2020,26(3):373-380.
[24] Wang J, Teng Z, Cui X, et al. Epidemiological and serological surveillance of hand-foot-and-mouth disease in Shanghai, China, 2012—2016[J]. Emerg Microbes Infect, 2018,7(1):8.
[25] Yang B, Liu F, Liao Q, et al. Epidemiology of hand, foot and mouth disease in China, 2008 to 2015 prior to the introduction of EV-A71 vaccine[J]. Euro Surveill. 2017,22(50):824.
[26] 邢志红, 叶植材. 中国统计年鉴[M]. 北京: 中国统计出版社, 2017: 1.
[27] 孟兆敏, 吴瑞君. 流动人口与户籍人口的收入差异及其影响因素: 以上海市为例[J]. 城市问题, 2016,6(1):82-91.
Outlines

/